 |
|
|
|
|
|
|
|
|
|
|
|
1 to 29 of 29 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Berchtold N, Cotman C. on NEWS: From Protein Trafficking to Episodic Memory: Tracing BDNF Genotypes, We were impressed by the research presented in Egan et al., which clinches a decisive role for... 3 Feb 2003.
|
|
|
 |
|
|
Cotman C. on PAPER: Su JH. et al., 1996, This is the first study to who that hyperphosphorlyated neurofilaments may precede tau... 4 Jul 2002.
|
|
|
|
|
|
Cotman C. on PAPER: Praticò D. et al., 2001, Context of the study. A major question in the study of brain aging and
dementia is:... 30 Jun 2002.
|
|
|
|
|
|
Cotman C. on PAPER: Zhao J. et al., 1996, Evidence that neurons are the primary source of A-beta. Astrocytes appear to be less critical No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Bonte FJ. et al., 1997, Important No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: DiPatre PL. et al., 1997, Interesting [that neuropathologic changes at the origin o fthe perforant pathway were correlated... No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Mattman A. et al., 1997, Interesting. See however Bonte et al, which reports an 86% sensitivity in autopsy confirmed cases No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Vito P. et al., 1996, A key new lead. Specificity may be dependent on the PC12 line No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Albert MS. et al., 1996, Important issue, thoughtfully presented No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Ji H. et al., 1997, Interesting idea [re: geneÕs homology to non-amyloid beta protein fragment of APP] No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Isoe K. et al., 1996, A very interesting genetics paper No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Woodruff-Pak DS. et al., 1997, Interesting No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Wolozin B. et al., 1996, An important study. See also Deng, et al in FEBS Letters 397 (1996) 50-54 No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Zhang S. et al., 1997, Reversibility is northy. No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Yamaoka LH. et al., 1996, New lead on subtype risk factors and their genetic basis. No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Nagy Z. et al., 1997, Interesting hypothesis [that in AD combined with cerebrovascular disease, the total plaque... No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Lendon CL. et al., 1997, Interesting No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Chan AS. et al., 1997, Interesting No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Ferrer I. et al., 1996, In general consistent with previous studies by our group and others. No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Pasinetti GM. et al., 1996, Interesting No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Ohm TG. et al., 1997, Interesting No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Kertesz A. et al., 1997, Interesting No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Brun A. et al., 1996, Interesting. Further data on ever-widening dementia populations. No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Wood SJ. et al., 1996, Helps clarify a very complex literature No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Rockwood K. et al., 1997, Important paper arguing that vascular disease is undertreated in patients with vascular dementia No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Chu CC. et al., 1997 Jan-Feb, New lead in an understudied aspect No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Imahori K. et al., 1997, This is an interesting paper which may indicate that A beta has a biphasic action on neurons,... No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Troncoso JC. et al., 1996, An exciting paper suggesting apoptosis in AD is related to beta amyloid. Agrees with previous... No date saved.
|
|
|
|
|
|
Cotman C. on PAPER: Gilfix BM. et al., 1997, Interesting No date saved.
|
|
|
|
|
|
|
1 to 29 of 29 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
